BETHESDA, Md. - Marylandian -- New bipartisan legislation—the Companion Animal Protection Against Cruel Testing (COMPACT) Act, introduced September 21, 2026, as H.R. 10522—was the focus of a September 23 press conference at the U.S. Capitol. The bill seeks to modernize federally funded biomedical research while strengthening protections for companion animals.

Dr. Zaher Nahle, Founder and CEO of Ivyctory Solutions, joined Representatives Nick Langworthy (R-NY) and Mark Pocan (D-WI), alongside national leaders including Wayne Pacelle of Animal Wellness Action, to deliver remarks on biomedical research modernization and federal research policy.

Speaking at the Capitol's House Triangle and summarizing the significance of the COMPACT Act, Dr. Nahle identified four priorities: protecting companion animals, preserving research that benefits their own health, improving accountability for taxpayer-funded research, and advancing American biomedical science toward better evidentiary standards—standards that are rigorous, innovative, and, above all, relevant to human health and physiology.

More on Marylandian

• Whose Ashes Are These? RetURN.org Launches Permanent IDs for Human and Pet Urns
• Technical Brief Examines Enterprise Integration Challenges as AI Agent Platforms Expand
• OncoBeta Introduces Rhenium-SCT for Non-Melanoma Skin Cancer at Theageneio Cancer Hospital of Thessaloniki
• Brian G. Miller Co., LLC Receives Tier 1 Ranking in the 2027 Edition of Best Law Firms®
• The Villari Firm, PLLC Named to the 2027 Edition of Best Law Firms

Dr. Nahle's participation, at the invitation of Congressman Langworthy's office, reflects the value placed on independent scientific analysis and underscores Ivyctory Solutions' growing role in providing substantive, evidence-based insights at the intersection of biomedical innovation, regulatory modernization, and public policy.

Dr. Nahle, who also serves as Senior Scientific Advisor to the Center for a Humane Economy, emphasized the need to modernize biomedical research, strengthen accountability for federal research investments, and evaluate scientific practices against measurable outcomes.

Drawing on findings from the Government Accountability Office, Dr. Nahle also raised concerns about the ability of federal agencies to accurately measure animal research expenditures and evaluate research performance. "What we cannot reliably measure, we cannot properly assess. And what we cannot assess, we cannot systematically improve," he told attendees.

Reflecting on the broader implications, Dr. Nahle emphasized the compatibility of scientific advancement and animal protection. "We do not have to choose between advancing human health or animal welfare. They can—and should—go hand in hand," he said.

More on Marylandian

• Bacchus Wine & Spirits and Michelin Guide–Recommended Ethel's Fancy to Host Exclusive LOUIS XIII Limited Edition Diwali Decanter Celebration
• Arizona Pest Control Surpasses $200,000 in Contributions to Southern Arizona High School Sports and Education Programs
• ZenaTech (NAS DAQ: ZENA) $1 Million in New Utility Contracts- Potential $2.5 Million Follow-On Opportunity Puts Its Drone Business in the Spotlight!
• New Patient Data Show REQORSA® Activating Cellular Repair Pathways as Roche Collaboration Advances Precision Lung Cancer Strategy for Genprex, Inc
• MapleLMS Awarded GMP Certification for Compliance Training

The event united lawmakers, research professionals, and national advocacy organizations to advance discussions about animal welfare, scientific innovation, federal research priorities, and responsible public policy.

Dr. Nahle's full remarks at the congressional event are accessible on LinkedIn (https://www.linkedin.com/feed/update/urn:li:activity:7508680358993895425/).

About Ivyctory Solutions

Ivyctory Solutions is a market research and strategic advisory firm specializing in biomedical innovation, life sciences, regulatory affairs, and public policy. The firm provides evidence-based analysis, market intelligence, and strategic insights to inform decision-making, evaluate emerging technologies, and navigate evolving scientific and regulatory landscapes.

Website: https://www.ivyctory.com